Cortes D, Thorup J, Visfeldt J
Department of Pediatric Surgery, Rigshospitalet, Copenhagen, Denmark.
J Urol. 2000 Apr;163(4):1290-2.
Hormonal treatment with human chorionic gonadotropin (HCG) or gonadotropin releasing hormone may be given initially for cryptorchidism. We evaluated whether hormonal treatment is safe for the germ cells in boys with cryptorchidism 1 to 3 years old in whom follicle-stimulating hormone, luteinizing hormone and testosterone values are normally low.
We measured the number of spermatogonia per tubule at orchiopexy in 72 consecutive boys with cryptorchidism who underwent simultaneous testicular biopsy. In 19 patients gonadotropin releasing hormone was unsuccessful, while 8 received HCG and 45 underwent orchiopexy without hormonal therapy. Groups were otherwise equal.
Patients who underwent surgery only had a higher number of spermatogonia per tubule than those in whom hormonal treatment was unsuccessful (p<0.05). Spermatogonia per tubule values were normal only after surgery alone (p = 0.06). Gonadotropin releasing hormone and HCG influenced germ cells equally.
In 1 to 3-year-old boys with cryptorchidism gonadotropin releasing hormone or HCG given for testicular descent may suppress the number of germ cells.
对于隐睾症,最初可给予人绒毛膜促性腺激素(HCG)或促性腺激素释放激素进行激素治疗。我们评估了激素治疗对于1至3岁隐睾症男孩生殖细胞是否安全,这类男孩的促卵泡激素、促黄体生成素和睾酮值通常较低。
我们对72例连续接受隐睾症手术并同时进行睾丸活检的男孩,在睾丸固定术中测量了每个曲细精管的精原细胞数量。19例患者促性腺激素释放激素治疗无效,8例接受了HCG治疗,45例未接受激素治疗直接进行了睾丸固定术。其他方面各组情况相同。
仅接受手术的患者每个曲细精管的精原细胞数量高于激素治疗无效的患者(p<0.05)。仅在手术后每个曲细精管的精原细胞数量才正常(p = 0.06)。促性腺激素释放激素和HCG对生殖细胞的影响相同。
对于1至3岁的隐睾症男孩,为使睾丸下降而给予促性腺激素释放激素或HCG可能会抑制生殖细胞数量。